Showing results (211-220 of 227) with videos related to
Sort By:
Pageof 23
Psychiatry Research|February 13, 2024
Sex differences in plasma proteomic markers in late-life depressionXiangning Xue, Derya Demirci, Eric J Lenze, et al.Science Translational Medicine|July 20, 2022
Miswiring of Merkel cell and pruriceptive C fiber drives the itch-scratch cycleJing Feng, Yonghui Zhao, Zili Xie, et al.Ebiomedicine|January 31, 2022
Alterations of host-gut microbiome interactions in multiple sclerosisClaudia Cantoni, Qingqi Lin, Yair Dorsett, et al.JAMA Oncology|September 1, 2022
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity SyndromeOmar H Butt, Alice Y Zhou, Paolo F Caimi, et al.The Journal of Clinical Investigation|January 26, 2023
A TRPV4-dependent neuroimmune axis in the spinal cord promotes neuropathic painXueming Hu, Lixia Du, Shenbin Liu, et al.Nature|August 14, 2020
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.Pageof 23